TA1 is supplied in single-use vials containing 1.6 mg of lyophilized product. After reconstitution with 1 mL of sterile water, TA1 is to be administered via subcutaneous injection. It should not ...

Other drugs under investigation for the same conditions as TA1 are an oral, broad-spectrum antiviral named adefovir dipivoxil, which is in Phase III trials in the United States for use in ...